Thus, a combination of basic serum biochemical markers appear to be useful for the diagnosis of clinically significant fibrosis (including early stages). A combination of basic serum markers helps to substantially reduce the number of liver biopsies done in patients with chronic HCV infection. However, these methods of fibrosis evaluation are still in their infancy and extensive research needs to be done to corroborate the early findings [42-44, 67].